US 11,666,771 B2
Implantable electrical leads and associated delivery systems
Rick Sanghera, San Clemente, CA (US); Brent Cadavona, San Diego, CA (US); Matthew Rollins, Lafayette, CO (US); Tim Searfoss, New Port Richey, FL (US); Brian Walguarnery, Tampa, FL (US); and Michel Gelineau, Hudson, FL (US)
Assigned to ATACOR MEDICAL, INC., San Clemente, CA (US)
Filed by ATACOR MEDICAL, INC., San Clemente, CA (US)
Filed on Nov. 29, 2020, as Appl. No. 17/106,152.
Application 17/106,152 is a continuation in part of application No. 16/888,462, filed on May 29, 2020.
Claims priority of provisional application 63/049,561, filed on Jul. 8, 2020.
Prior Publication US 2021/0370080 A1, Dec. 2, 2021
Int. Cl. A61N 1/05 (2006.01); A61N 1/39 (2006.01)
CPC A61N 1/39622 (2017.08) [A61N 1/059 (2013.01); A61N 1/0597 (2013.01)] 57 Claims
OG exemplary drawing
 
1. An electrical lead for implantation in a patient, the lead comprising:
a distal portion comprising one or more electrodes that are configured to generate therapeutic energy for biological tissue of the patient; and
a proximal portion coupled to the distal portion and configured to engage a controller, the controller configured to cause the one or more electrodes to generate the therapeutic energy,
wherein the distal portion is configured to split apart into sub-portions that travel in multiple directions during implantation into the patient, and
wherein the distal portion is wider than it is thick and the proximal portion is configured to be thinner than the distal portion in a manner that facilitates removal from a delivery system.